MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 196 filers reported holding MIRATI THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.46 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $225,000 | -57.0% | 1,272 | -46.6% | 0.08% | -95.8% |
Q4 2020 | $523,000 | +31.4% | 2,380 | -0.7% | 1.97% | +801.8% |
Q3 2020 | $398,000 | +44.7% | 2,396 | -0.5% | 0.22% | +33.7% |
Q2 2020 | $275,000 | +2.2% | 2,407 | +15.3% | 0.16% | +71.6% |
Q4 2019 | $269,000 | +11.2% | 2,087 | -36.7% | 0.10% | +6.7% |
Q1 2019 | $242,000 | – | 3,296 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $688,784,000 | 67.42% |
Avoro Capital Advisors LLC | 4,535,000 | $996,067,000 | 17.15% |
Darwin Global Management, Ltd. | 260,876 | $57,299,000 | 15.99% |
Boxer Capital, LLC | 1,765,560 | $387,788,000 | 12.46% |
Perceptive Advisors | 3,693,516 | $811,244,000 | 8.71% |
Consonance Capital Management LP | 330,000 | $72,481,000 | 6.77% |
EcoR1 Capital, LLC | 464,298 | $101,978,000 | 5.48% |
Fairmount Funds Management LLC | 60,500 | $13,288,000 | 4.75% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,400 | $14,804,000 | 4.04% |
RTW INVESTMENTS, LP | 1,054,364 | $231,581,000 | 3.88% |